Makary Resigns as FDA Commissioner Following Policy Disputes - Summary - MDSpire
FDA & Government News

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

  • By

  • Kathryn Wighton

  • May 12, 2026

  • 2 min

Share

Dr. Marty Makary resigned as the US FDA Commissioner after 13 months, during which he faced significant challenges, including workforce reductions and policy disputes. His tenure began in March 2025 amid the COVID-19 pandemic and was marked by controversy over pediatric mask mandates and vaccine guidelines. Under his leadership, the FDA prioritized vaccine policy, dietary guidance, and food additive regulations, and he took steps to phase out synthetic food dyes. His resignation was influenced by Secretary Robert F. Kennedy Jr. and the White House.

Original Source(s)

Makary Resigns as FDA Commissioner Following Policy Disputes

  • by Kathryn Wighton

  • May 12, 2026

Related Content

Breaking the “Black Box” in Bioprocessing

Why understanding titer analytics is key to faster, more reliable biologics and gene therapy development

  • May 14, 2026

  • 10 min
AI Discharge Summaries Show Low Harm Risk

Most reviewed summaries were rated as posing no harm risk, although omissions remained common.

Uric Acid Stone Dissolution Peaked at pH 7.2

In vitro study found dissolution rates increased sharply above pH 6.5 and were tenfold higher after stone fragmentation.